EUVIMEDEUVIMED entdecken
Crossref

Targeting VAMP5 suppresses PLK1-driven growth of gliomas with high NDRG4 expression

Yinghao Zhang, Haoran Wang, Jinhai Wang, Yufang Sui, Wanhong Zhang, Xuhong Lin, Pengpai Zhang

Journal of Neuro-Oncology · 2026-06 · 178 (2)

DOI: 10.1007/s11060-026-05666-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, online erschienen am 08.06.2026. Verfasst von Yinghao Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science, Henan University, Kaifeng, 475001, China. Hauptthemen laut MEDLINE: Glioma, Cell Cycle Proteins, Proto-Oncogene Proteins, Protein Serine-Threonine Kinases. Die Arbeit nennt 90 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: SNAREs participate in tumor progression; however, existing studies on SNAREs remain fragmented. The discovery of suitable SNARE targets and delineation of their application limits are critical. METHODS: We performed integrative analyses on clinical data and RNA-seq data from TCGA to identify therapeutic targets in defined cancer subtypes. These in silico findings were substantiated in patient-derived tumor sections, glioma cell lines, and xenografts. Gene/microRNA expression was modulated through lentiviral transduction. Omics methods, including RNA-seq, microRNA sequencing, and data-independent acquisition proteomics, were used to localize/quantify downstream effectors, followed by characterization with antibody-based tests. MicroRNA sponge constructs were validated with qPCR. RESULTS: We evaluated VAMP5 as a glioma-selective therapeutic target and found two distinct response phenotypes following VAMP5 knockdown (KD). In the VAMP5-KD-sensitive subgroup, VAMP5 depletion universally suppressed PLK1, partly by reducing novel upregulatory microRNAs (miR-1301-3p and miR-12135), thereby inhibiting tumor cell proliferation. However, PLK1 expression remained unchanged in VAMP5-KD-insensitive tumors, making PLK1 a reliable pharmacodynamic marker. High NDRG4 expression predicted sensitivity to VAMP5 KD. NDRG4 overexpression induced in insensitive glioma lines converted them to a sensitive phenotype, enabling VAMP5-KD-induced PLK1 downregulation through coordinated modulation of additional microRNAs (classical tumor-suppressive miR-509-5p upregulation and novel upregulatory miR-1185-3p downregulation) and TNKS reduction (which was also shown to contribute to PLK1 downregulation in a subset of VAMP5-KD-sensitive lines). This NDRG4 OE plus VAMP5 KD cascade also diminished the immune checkpoint ligand VCAM1. We identified LGALS1 as a universal VAMP5-coexpressed immune modulator, suggesting that VAMP5 KD may further enhance antitumor immunity by downregulating LGALS1. CONCLUSIONS: Our work provides a preliminary mechanistic framework for VAMP5 KD-mediated glioma suppression on proliferation or immune evasion and highlights several translational opportunities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaCell Cycle ProteinsProto-Oncogene ProteinsProtein Serine-Threonine KinasesNerve Tissue ProteinsBrain NeoplasmsR-SNARE ProteinsHumansAnimalsCell ProliferationMicroRNAsPolo-Like Kinase 1Gene Expression Regulation, NeoplasticMiceCell Line, TumorMuscle Proteins

Stichwörter der Autor:innen

GliomasLGALS1NDRG4PLK1TNKSUp-regulatory microRNAsVAMP5VCAM1

Substanzen

Cell Cycle ProteinsProto-Oncogene ProteinsProtein Serine-Threonine KinasesNerve Tissue ProteinsR-SNARE ProteinsMicroRNAsPolo-Like Kinase 1NDRG4 protein, humanMuscle Proteins

Autor:innen und Institutionen

  • College of Life Science, Henan University, Kaifeng, 475001, China.
  • Department of Child Developmental Behavior, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
  • Department of Neurosurgery, Kaifeng Central Hospital, Kaifeng, 475000, China.
  • Department of Clinical Laboratory, Huaihe Hospital of Henan University, Kaifeng, 475099, China. 10220017@vip.henu.edu.cn.
  • College of Life Science, Henan University, Kaifeng, 475001, China. zhangpengpai@henu.edu.cn.

Förderung

  • Natural Science Foundation of Henan Province

Zitieren

APA

Zhang, Y., Wang, H., Wang, J., Sui, Y., Zhang, W., Lin, X., & Zhang, P. (2026). Targeting VAMP5 suppresses PLK1-driven growth of gliomas with high NDRG4 expression. Journal of Neuro-Oncology, 178(2). https://doi.org/10.1007/s11060-026-05666-5

Vancouver

Zhang Y, Wang H, Wang J, Sui Y, Zhang W, Lin X, et al. Targeting VAMP5 suppresses PLK1-driven growth of gliomas with high NDRG4 expression. Journal of Neuro-Oncology. 2026;178(2). doi:10.1007/s11060-026-05666-5

BibTeX
@article{Zhang2026,
  author = {Zhang, Yinghao and Wang, Haoran and Wang, Jinhai and Sui, Yufang and Zhang, Wanhong and Lin, Xuhong and Zhang, Pengpai},
  title = {Targeting VAMP5 suppresses PLK1-driven growth of gliomas with high NDRG4 expression},
  journal = {Journal of Neuro-Oncology},
  year = {2026},
  volume = {178},
  number = {2},
  doi = {10.1007/s11060-026-05666-5}
}
Kostenlos starten →